LIMN reverse split history: Liminatus Pharma, Inc. Class A Common Stock
Listed on Nasdaq. Split dates, ratios and the filings behind them.
Split history
| Effective date | Direction | Ratio | Status |
|---|---|---|---|
| Aug 21, 2026 | Reverse | 1 to 50 | Took effect |
Exchange listing context
- bid price deficiencyNASDAQfiled Sep 29, 2026
Listing Rule 5450(a)(1). Estimated compliance period ends Mar 28, 2027. Marked resolved on Sep 29, 2026.
SEC filing 000110465926111665 - bid price deficiencyNASDAQfiled Aug 18, 2026
Listing Rule 5550(a)(2). Estimated compliance period ends Feb 14, 2027. Marked resolved on Aug 18, 2026.
SEC filing 000110465926098335 - bid price deficiencyNASDAQfiled Jul 24, 2026
Listing Rule 5810(b). Estimated compliance period ends Jan 20, 2027. Marked resolved on Jul 24, 2026.
SEC filing 000110465926086674 - general deficiencyNASDAQfiled May 27, 2026
Listing Rule 5450(b)(2)(A). Marked resolved on May 27, 2026.
SEC filing 000110465926066974 - bid price deficiencyNASDAQfiled Jan 26, 2026
Listing Rule 5810(b). Estimated compliance period ends Jul 24, 2026. Not marked resolved in the index.
SEC filing 000110465926006619 - delisting noticeNASDAQfiled Nov 25, 2025
Listing Rule 5810(b). Not marked resolved in the index.
SEC filing 000110465925116049
Exchange deficiency notices Signal8 detected in 8-K Item 3.01 filings. No notice listed means none was found in that index, not that the company is in compliance.
Approval timeline
Locked1 tracked episode on record. Every filing and step from proposal to effective date.
Included with SplitScanner ($9.99 a month) and Signal8 Pro.
Unlock with SplitScannerHow it traded after each split
Locked1 executed reverse split on record. The move over the 30 days after each one, on one split basis.
Included with SplitScanner ($9.99 a month) and Signal8 Pro.
Unlock with SplitScannerFloat before and after
Locked102 float samples on record. Float around each split, from the daily float record.
Included with SplitScanner ($9.99 a month) and Signal8 Pro.
Unlock with SplitScannerAI summaries of the filings
Locked5 analysed filing or releases on record. Plain-English readings of each filing and press release about the split, from the Signal8 analysis.
Included with SplitScanner ($9.99 a month) and Signal8 Pro.
Unlock with SplitScannerSplit dates and ratios come from the market split calendar and are cross-checked against a second source; a row only one source evidences is marked unconfirmed. Funds, ETFs and other non-equity securities are excluded. The index is keyed by ticker symbol, so a company that changed symbol between splits appears under each symbol.